Search

Filters

Clear Filters
5:05 PM - 5:10 PM ET

1084 - Solitary Plasmacytoma Treated by Lenalidomide and Dexamethasone in Combination with Radiation Therapy: Long Term Clinical Outcomes
Speaker: Kirova, Youlia, MD - Institut Curie, Paris, Paris
5:10 PM - 5:15 PM ET

1085 - A Phase II Single-arm Study of Total Body Irradiation With Linac Based Volumetric Modulated Arc Therapy (VMAT) Total Body Irradiation (TBI)
Speaker: Shaikh, Fauzia, MD - NYU Langone Health- Radiation Oncology, New York, NY
5:15 PM - 5:20 PM ET

1086 - PD-1/PD-L1 Blockade Added to First-Line Asparaginase-Based Chemotherapy with or without Radiotherapy in Extranodal Nasal-Type NK/T-Cell Lymphoma: A Multicenter Retrospective Study from the CLCG
Speaker: Liu, Yue - Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC, Beijing
5:20 PM - 5:25 PM ET

1087 - Fast Forward: Hypofractionated, Dose De-escalated Radiotherapy for Multiple Myeloma
Speaker: Deshane, Alok, MD - MSKCC, New York, NY
5:25 PM - 5:30 PM ET

1088 - Baseline Metabolic Tumor Volume Predicts Survival In Relapsed/Refractory Aggressive B-cell Lymphoma Patients Treated with Bispecific Antibodies: A Multi-Institution Discovery-Validation Study
Speaker: Johnson, Bryan, MD, MBA - Mayo Clinic Florida, Jacksonville, FL
5:30 PM - 5:35 PM ET

1089 - Radiation Therapy for Bridging to CD19 CAR T-Cell Therapy for Large B-Cell Lymphoma - A Multicenter Analysis by the GoCART Coalition and the EBMT Lymphoma Working Party
Speaker: Oertel, Michael, MD, PhD - University Hospital of Muenster, Muenster, Nordrhein-
3:40 PM - 3:50 PM ET

109 - <em>I</em>ntermittent Androgen Deprivation Therapy with or without <em>St</em>ereotactic Body Radiotherapy for Molecularly Identified Hormone Sensitive <em>O</em>ligometastatic <em>P</em>rostate Cancer: A Randomized Study (i-STOP)
Speaker: Glicksman, Rachel, MD - University of Toronto, Toronto, ON
5:35 PM - 5:40 PM ET

1090 - BALT-NRI: A Novel Prognostic Model for Bronchus-Associated Lymphoid Tissue Lymphoma with Disease-Specific Survival Implications
Speaker: Wang, Yu, MD - Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing
5:05 PM - 5:10 PM ET

1091 - Phase III Trial to Compare Weekly and Triweekly Usage of Docetaxel and Cisplatin in Concurrent Chemoradiotherapy for Patients with Unresectable Locally Advanced Non-Small Cell Lung Cancer
Speaker: Yang, Dan, MD - Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, P.R. China, Beijing
5:10 PM - 5:15 PM ET

1092 - Coronary Artery Calcifications and Major Adverse Cardiac Events after Radiation Therapy for Locally-Advanced Non-Small Cell Lung Cancer
Speaker: Kelsey, Christopher, MD, FASTRO - Duke University Medical Center, Durham, North Carolina
5:15 PM - 5:20 PM ET

1093 - Real-World Outcomes of Radiotherapy Alone in 1802 Patients with Stage II-III NSCLC
Speaker: van Diessen, Judi, MD, PhD - NKI-AvL, Amsterdam, Noord-Holl
5:20 PM - 5:25 PM ET

1094 - Risk Classifier for Treatment of Stage III Non-Small Cell Lung Cancer Using Competing Event Regression: Ancillary Analysis of RTOG 0617
Speaker: Morse, Ryan, MD - University of Kansas Medical Center, Kansas City, KS